Management | Compatible spirometry, % N= 6702 | Incompatible spirometry, % N= 2255 | P-value |
---|---|---|---|
3-month review | 0.93 | 1.46 | 0.03 |
6-month review | 1.06 | 1.60 | 0.04 |
12-month review | 96.51 | 95.04 | 0.002 |
No review | 1.5 | 1.9 | 0.2 |
Smoking cessation advicea | 96.2 | 96.9 | 0.3 |
Smoking cessation referrala | 3.7 | 3.1 | 0.3 |
No smoking cessation recorda | 0.1 | 0 | 0.3 |
Influenza vaccination | 89 | 89 | 0.6 |
Inhaler technique | 95 | 95 | 0.3 |
Pulmonary rehabilitation referral | 23 | 20 | 0.001 |
Oxygen therapy | 3 | 2 | 0.04 |
LABA | 33 | 30 | 0.07 |
LAMA | 81 | 73 | <0.001 |
ICS | 49 | 52 | 0.07 |
Combined LABA/ICS | 78 | 75 | 0.002 |
current smokers. Unpaired Student’s t-test and χ2 square test used to evaluate differences between groups. COPD = chronic obstructive pulmonary disease. ICS = inhaled corticosteroid. LABA = long-acting beta-agonist. LAMA = long-acting muscarinic antagonist.